Your session is about to expire
← Back to Search
Other
High Resolution Retina Imaging (IHR Trial)
N/A
Waitlist Available
Led By Michel PAQUES
Research Sponsored by Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from date of inclusion until the date of last documented progression , assessed up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
To increase the clinical experience of using the rtx1 camera in various retinal disorders and to follow the evolution of structural alterations during retinal diseases using adaptive optics imaging with the rtx1 camera
Eligible Conditions
- Diabetic Retinopathy
- Retinitis Pigmentosa
- Retinal Vein Occlusion
- Macular Degeneration
- Macular Edema
- High Blood Pressure
- Retinal Degeneration
- Cystoid Macular Edema
- Age-Related Macular Degeneration
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from date of inclusion until the date of last documented progression , assessed up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from date of inclusion until the date of last documented progression , assessed up to 5 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Evolution of retina diseases
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Find a Location
Who is running the clinical trial?
Centre Hospitalier National d'Ophtalmologie des Quinze-VingtsLead Sponsor
21 Previous Clinical Trials
7,046 Total Patients Enrolled
1 Trials studying Diabetic Retinopathy
270 Patients Enrolled for Diabetic Retinopathy
Michel PAQUESPrincipal InvestigatorCentre Hospitalier National d'Ophtalmologie des Quinze-Vints
2 Previous Clinical Trials
2,400 Total Patients Enrolled